Guobang Pharma Ltd (605507)
Shanghai Stock Exchange · China · prices in CNY · close of 27 Oct 2026
Key indicators
| Last close | CNY 14.80 |
|---|---|
| 52-week range | 14.34 – 20.82 |
| Return, 1 month / 3 months | −18.2% / −6.2% |
| Return, 1 year / 3 years | −6.1% / +14.0% |
| Trend | Below its 200-day average |
| RSI (14) | 31 |
| Volatility (1 year) | 33.5% |
| Worst drawdown (1 year) | -27.6% |
| Average daily value traded | 126.62M CNY |
| Dividend yield | 4.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
Summary
Guobang Pharma Ltd (605507) trades on the Shanghai Stock Exchange in China. It last closed at CNY 14.80 on 27 October 2026.
Its price-based Market X-Ray is 70 out of 100 (a strong price profile), ranking 304 of 2,280 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 6.1% and over the last three months it fell 6.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Shanghai Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 70 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -12.0% | ||
| From 52-week high | -27.2% | ||
| Momentum | 62 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -6.2% | ||
| 6-month return | -11.1% | ||
| 12-month return, skipping the last month | 14.8% | ||
| Stability (higher is calmer) | 83 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 33.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -27.6% | ||
| Liquidity | 48 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 126.62M CNY | ||
| Zero-volume days | 0.0% | ||
| Income | 95 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 4.1% | ||
| Years with dividends | 6 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −4.7% |
|---|---|
| 1 month | −18.2% |
| 3 months | −6.2% |
| 6 months | −11.1% |
| 1 year | −6.1% |
| 3 years | +14.0% |
| 5 years | −12.1% |
Signals
| 50-day / 200-day average | 16.23 / 16.82 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.58 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 May 2026 | CNY 0.6000 |
| 13 Jun 2025 | CNY 0.6058 |
| 14 Jun 2024 | CNY 0.3015 |
| 22 May 2023 | CNY 0.6000 |
| 10 Jun 2022 | CNY 0.2000 |
| 17 Nov 2021 | CNY 0.5000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Shanghai Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.